A5057798061- Bone health and treatments
- Bone health and osteoporosis research
- Bone Metabolism and Diseases
- Biochemical effects in animals
- Biomarkers in Disease Mechanisms
- Photoreceptor and optogenetics research
- Neurobiology and Insect Physiology Research
- Orthoptera Research and Taxonomy
- Neurological Disorders and Treatments
- Neuropeptides and Animal Physiology
- Bone and Joint Diseases
- Human Health and Disease
- Hip and Femur Fractures
Novosibirsk State Medical University
2018-2021
Ministry of Health of the Russian Federation
2020
Institute of Evolutionary Physiology and Biochemistry
1978-1983
Aim.. To study clinical and pathogenic relationships between the development of chronic heart failure (CHF) ischemic genesis associated with type 2 diabetes mellitus (DM) osteoporosis in postmenopausal women to evaluate effects anti-osteoporotic therapy on CHFMethods Methods. A total 178 were recruited study. All patients assigned three groups: Group 1 (n = 48) CHF DM, 93) – CHF, 3 37) osteoporosis, mellitus. The control group comprised 35 healthy period without signs symptoms cardiovascular...
Aim. To study the link of increased serum concentrations osteoprotegerin (OPG) in patients with chronic heart failure (CHF) associated type 2 diabetes mellitus (DM 2), osteoporosis or osteopenia development cardiovascular events (primarily, decompensation CHF, including those requiring hospitalization, death from disease, acute coronary syndrome ischemic stroke) to determine possibility using this biomarker as a predictor severe course disease these patients. Materials and methods. In...
To study the effectiveness of oral alendronate and ibandronate bisphosphonates for prevention cardiovascular complications in postmenopausal women with type 2 diabetes mellitus (DM) osteoporosis during a 12-month prospective observation.The included 86 osteoporosis, chronic heart failure (CHF) diabetes: 1st group (n=52) patients who received basic therapy failure; 2nd (n=34) who, addition to failure, were prescribed alendronic ibandronic acid preparations treatment osteoporosis. In order...
Introduction . Diabetes mellitus, cardiovascular diseases and osteoporosis are linked by common pathophysiological mechanisms. Objective To evaluate the effect of alendronate bisphosphonate on outcomes in comorbid patients with ischemic heart disease (CHD) associated type 2 diabetes mellitus (type diabetes) during a two-year follow-up. Materials methods A total 112 women pathology including osteoporosis, coronary artery disease, were examined. The patients' condition was assessed at baseline...